Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Stock Forecast

Stock Price Forecast

The 2 analysts that cover Strata Critical Medical stock have a consensus rating of "Strong Buy" and an average price target of $7.63, which forecasts a 67.32% increase in the stock price over the next year. The lowest target is $7.25 and the highest is $8.00.

Price Target: $7.63 (+67.32%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.25	$7.63	$8.00	$8.00
Change	+58.99%	+67.32%	+75.44%	+75.44%

* Price targets were last updated on Dec 2, 2025.

Analyst Ratings

The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Benjamin Haynor Lake Street	Lake Street	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+75.44%	Dec 2, 2025
Ben Klieve Lake Street	Lake Street	Strong Buy Maintains $6.5 → $7.25	Strong Buy	Maintains	$6.5 → $7.25	+58.99%	Sep 17, 2025

Financial Forecast

Revenue This Year

271.83M

Increased by 37.89%

from 197.14M

Revenue Next Year

310.79M

Increased by 14.33%

from 271.83M

EPS This Year

-0.06

from 0.50

EPS Next Year

-0.03

from -0.06

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	67.16M	146.12M	225.18M	146.82M	197.14M	271.83M	310.79M
Revenue Growth	32.92%	117.58%	54.11%	-34.80%	34.28%	37.89%	14.33%
EPS	-0.68	-0.38	-0.76	-0.35	0.50	-0.06	-0.03
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	283.5M	319.9M
Avg	271.8M	310.8M
Low	257.7M	298.6M

Revenue Growth

Revenue Growth	2026	2027
High	43.8%	17.7%
Avg	37.9%	14.3%
Low	30.7%	9.9%

EPS Forecast

EPS	2026	2027
High	0.08	-0.03
Avg	-0.06	-0.03
Low	-0.19	-0.03

EPS Growth

EPS Growth	2026	2027
High	-83.3%	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.